Molecular signatures of hemagglutinin stem-directed heterosubtypic human neutralizing antibodies against influenza A viruses. - Test2 - elhamkhani - TriplyDB

Molecular signatures of hemagglutinin stem-directed heterosubtypic human neutralizing antibodies against influenza A viruses.

Molecular signatures of hemagglutinin stem-directed heterosubtypic human neutralizing antibodies against influenza A viruses.

http://www.wikidata.org/entity/Q33553746

about

Influenza vaccines: a moving interdisciplinary field.A humanized neutralizing antibody against MERS-CoV targeting the receptor-binding domain of the spike protein.Immune history profoundly affects broadly protective B cell responses to influenza.Investigating the effect of AS03 adjuvant on the plasma cell repertoire following pH1N1 influenza vaccination Bispecific antibody generated with sortase and click chemistry has broad antiinfluenza virus activity Sequencing of the human IG light chain loci from a hydatidiform mole BAC library reveals locus-specific signatures of genetic diversity Structure of the apo anti-influenza CH65 Fab.Predominant structural configuration of natural antibody repertoires enables potent antibody responses against protein antigens Association of VH4-59 Antibody Variable Gene Usage with Recognition of an Immunodominant Epitope on the HIV-1 Gag Protein Discovering neutralizing antibodies targeting the stem epitope of H1N1 influenza hemagglutinin with synthetic phage-displayed antibody libraries.H5N1 Vaccine-Elicited Memory B Cells Are Genetically Constrained by the IGHV Locus in the Recognition of a Neutralizing Epitope in the Hemagglutinin Stem.Recombinant antibodies for diagnostics and therapy against pathogens and toxins generated by phage display.Generation of Recombinant Antibodies Against Toxins and Viruses by Phage Display for Diagnostics and Therapy.IGHV1-69 polymorphism modulates anti-influenza antibody repertoires, correlates with IGHV utilization shifts and varies by ethnicity Statistical inference of a convergent antibody repertoire response to influenza vaccine Both Neutralizing and Non-Neutralizing Human H7N9 Influenza Vaccine-Induced Monoclonal Antibodies Confer Protection Selection of therapeutic H5N1 monoclonal antibodies following IgVH repertoire analysis in mice.A broadly neutralizing anti-influenza antibody reveals ongoing capacity of haemagglutinin-specific memory B cells to evolve.Germline-encoded neutralization of a Staphylococcus aureus virulence factor by the human antibody repertoire An anti-DNA antibody prefers damaged dsDNA over native.Restricted, canonical, stereotyped and convergent immunoglobulin responses.Preferential induction of cross-group influenza A hemagglutinin stem-specific memory B cells after H7N9 immunization in humans.Heads, stalks and everything else: how can antibodies eradicate influenza as a human disease?In vitro reconstitution of B cell receptor-antigen interactions to evaluate potential vaccine candidates.Investigating Substitutions in Antibody-Antigen Complexes Using Molecular Dynamics: A Case Study with Broad-spectrum, Influenza A Antibodies.Strategies to induce broadly protective antibody responses to viral glycoproteins.A Perspective on the Structural and Functional Constraints for Immune Evasion: Insights from Influenza Virus.Potent Plasmablast-Derived Antibodies Elicited by the National Institutes of Health Dengue Vaccine.Antibody Prophylaxis Against Dengue Virus 2 Infection in Non-Human Primates.A novel antibody discovery platform identifies anti-influenza A broadly neutralizing antibodies from human memory B cells.Rapid development of broadly influenza neutralizing antibodies through redundant mutations.Antibody 27F3 Broadly Targets Influenza A Group 1 and 2 Hemagglutinins through a Further Variation in VH1-69 Antibody Orientation on the HA Stem.Structural insights into the design of novel anti-influenza therapies.Universal influenza vaccine design: directing the antibody repertoire

P2860

Q30367695-321EBAF1-E57E-431C-BC98-0B6CEB61136C Q30379384-77B58D32-8410-488E-8922-68024C2E8100 Q30382131-A2121D39-F0F6-489C-BEA7-09B2DBE18CC1 Q30395263-0B55DD3A-ABAA-4293-8DCE-6F8B8B718BE0 Q34601167-0E51AA67-68AB-4B69-9363-5AA9F1AC21F4 Q35007784-B78B7EC7-37FD-4295-B75D-A9FB92076F53 Q35063209-C1E1D69C-194D-424F-8DA0-7737E965F274 Q35707409-32F69363-A729-43FF-A2D8-9AD4EAE2DECA Q35726702-621ED87A-49A2-40D9-BDC3-A52429580EF7 Q35803118-45F81BB6-6F2F-4BF4-899F-9EFEB895683A Q35815943-A41F06FD-6022-4067-ADE2-56546E2C6CB7 Q36023082-ED72437D-5FFD-43B1-9FA6-72090B348BA1 Q36033286-E5CAE8D9-A781-4A91-8109-9F03AFF53011 Q36583070-E434AA93-6FD6-4A2F-B3AB-9ED6A99DEB0E Q36965474-A4E286BD-26D5-46E2-808E-E9846572ADB0 Q36991414-E10AB5FF-60F8-4423-856C-96603FAAEEE5 Q37069543-2B136415-0D37-4E51-98A2-EA3F1DA1E178 Q37263716-A953D1F9-8F62-4146-AE45-72536E81D334 Q37430689-27BDCEEF-752D-4972-A2ED-1BA61DF30E67 Q38294894-354C0203-5308-4D7B-82E0-F23360E6A9BC Q38551067-6441CF1E-E092-48BA-833A-AFE1E050E918 Q38636861-95CE8C8E-413A-48DF-AACC-8BC3C8747AAC Q38804059-1232FA29-F282-40CD-AD37-B572705B2419 Q38805907-C0C9619F-BA66-442F-A2F3-8B7F77914580 Q38928519-1D9FD81A-0ACA-4D09-BF88-A9E1B14D723D Q39170802-F872FF29-2B99-49FD-9193-BB59E3C1B351 Q39397313-740AC4F6-1701-4A60-BA6A-7CA292435EED Q40040450-6B54AF33-FB27-4937-9E51-2D39B36EA01F Q40081626-DCDF7BE1-B2B9-4513-ADCD-37CB04F104F9 Q40726829-4F6D4ECF-64FD-4308-86E6-087F8D59E3F7 Q41710834-C4721101-99DB-483E-BBD9-760441A53320 Q41933744-DE674B80-03CC-40DA-BAB5-A1FEE5EC754D Q48113181-F7FD680F-0C37-4068-951A-3E2E6B489915 Q58003557-98BB6377-4EFE-4283-BF3B-C5FBE2C02E07

P2860

Molecular signatures of hemagglutinin stem-directed heterosubtypic human neutralizing antibodies against influenza A viruses.

http://www.wikidata.org/entity/Q33553746

description

2014 nî lūn-bûn

@nan

2014 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Molecular signatures of hemagg ...... s against influenza A viruses.

@ast

Molecular signatures of hemagg ...... s against influenza A viruses.

@en

Molecular signatures of hemagg ...... s against influenza A viruses.

@nl

type

label

Molecular signatures of hemagg ...... s against influenza A viruses.

@ast

Molecular signatures of hemagg ...... s against influenza A viruses.

@en

Molecular signatures of hemagg ...... s against influenza A viruses.

@nl

prefLabel

Molecular signatures of hemagg ...... s against influenza A viruses.

@ast

Molecular signatures of hemagg ...... s against influenza A viruses.

@en

Molecular signatures of hemagg ...... s against influenza A viruses.

@nl

P1433

Q33553746-EC5CCD63-7F46-4166-9FD4-D9D05E075911

P1476

Q33553746-58D54F64-A3C1-47F5-A3A8-C9287A7D0A81

P2093

Q33553746-0788AFA3-E5EC-492B-827E-7F3254D23E29

Q33553746-125AEB3B-C8D5-47E8-A170-250C36E644F8

Q33553746-246F0798-89AC-4329-9DCB-7DA4CA20E422

Q33553746-24E304CC-FAF0-47EA-92FA-CD07950A7FF4

Q33553746-624243D9-28E5-4685-BAE1-5CA68C4E3F85

Q33553746-6AAE3D67-F20E-466D-B0A6-696DCD5D7720

Q33553746-6FCABC60-8EF5-46A7-ACEA-9807EBE18FB5

Q33553746-781CB347-EDFE-47A2-8D51-6B4023696B95

Q33553746-A5064713-559E-449D-9F12-E3C1ACF14F71

Q33553746-AF9BECE4-F992-4848-A3FE-6F463FB588D0

P2860

Q33553746-02D4E45F-D146-496D-B965-00CAF03B8826

Q33553746-12B2E61C-6947-4129-ACE3-AEB27AEBDE7C

Q33553746-1D95B6FC-26F3-4FA5-934E-845B0501B640

Q33553746-1E5C39B0-F3EB-4515-92EF-7AABBDBF6B2F

Q33553746-26FAD4A9-2669-4717-B2E1-7F51616B4AC3

Q33553746-2D798384-C040-4E91-861B-85FF91FBAD3A

Q33553746-2FEBFCA3-CD83-41CA-AB63-D3C69584F16D

Q33553746-33D2941F-8DB4-4AE6-B4F1-AEB05108B659

Q33553746-42A5B9FE-3D7C-45F3-9B57-17984236B1C0

Q33553746-474A7040-BCD6-4C48-9FB9-97032B0B36E4

P304

Q33553746-735524FA-2B16-4954-BDA1-7B35281C3230

P31

Q33553746-9CAAB8FD-11CE-488D-A2F1-B89808C8D6F5

P356

Q33553746-DA802854-2104-413D-B5DD-9681DE4737D0

P433

Q33553746-210AF15D-D6F2-48C6-A442-81F1B2F6A51C

P478

Q33553746-8E50392D-EFA0-41D7-8869-1939F323590F

P50

Q33553746-9C318EAA-0953-43A3-A5A7-7297734D1C18

P577

Q33553746-AC5D04C9-ED59-45B4-BDDA-402554C91B1F

P5875

Q33553746-47381C01-48DD-411B-AA06-408BC0AE17AF

P698

Q33553746-98443723-2C20-4425-940B-C31D25EAA97E

P921

Q33553746-17B5BAFE-AC4B-48B9-85C4-2F96463AB3D8

P932

Q33553746-1A7F1308-F92B-4422-AD61-474CAFB44EB5

P356

JOURNAL.PPAT.1004103

P1433

P1476

Molecular signatures of hemagg ...... s against influenza A viruses.

@en

P2093

Aimee S Tallarico

http://www.w3.org/2001/XMLSchema#string

Amr Fahmy

http://www.w3.org/2001/XMLSchema#string

Andrew S Bennett

http://www.w3.org/2001/XMLSchema#string

Chiung-yu Huang

http://www.w3.org/2001/XMLSchema#string

Gene Connelly

http://www.w3.org/2001/XMLSchema#string

Gerhard Wagner

http://www.w3.org/2001/XMLSchema#string

Greg Cadwell

http://www.w3.org/2001/XMLSchema#string

Jared Sheehan

http://www.w3.org/2001/XMLSchema#string

Jianhua Sui

http://www.w3.org/2001/XMLSchema#string

Laurie A Bankston

http://www.w3.org/2001/XMLSchema#string

P2860

Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells

A highly conserved neutralizing epitope on group 2 influenza A viruses

Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses

Antibody recognition of a highly conserved influenza virus epitope

A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins

Highly Conserved Protective Epitopes on Influenza B Viruses

Focused Evolution of HIV-1 Neutralizing Antibodies Revealed by Structures and Deep Sequencing

Antibody modeling assessment

Rational HIV Immunogen Design to Target Specific Germline B Cell Receptors

A common solution to group 2 influenza virus neutralization

P304

e1004103

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PPAT.1004103

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262025069

http://www.w3.org/2001/XMLSchema#string

P698

24788925

http://www.w3.org/2001/XMLSchema#string

P921

P932

4006906

http://www.w3.org/2001/XMLSchema#string